Pharma Co. Altacor Closes $3M Tranche
UK-based Altacor, an ophthalmic specialty pharmaceutical company, has closed a 1.9 million pounds ($3 million) second tranche of a total 3.4 million pound ($5.48 million) financing round. NVM Private Equity led the tranche, which included participation from Enterprise Ventures and Beringea. The first tranche closed in the autumn 2010 and was led by Esperante. The Aspire Fund and other unnamed investors also participated.
8 February 2011•3 mins read
